Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 314

1.

Aetiologies and temporal trends of atrioventricular block in young patients: a 20-year nationwide study.

Rudbeck-Resdal J, Christiansen MK, Johansen JB, Nielsen JC, Bundgaard H, Jensen HK.

Europace. 2019 Aug 19. pii: euz206. doi: 10.1093/europace/euz206. [Epub ahead of print]

PMID:
31424500
2.

Incidence of appropriate implantable cardioverter-defibrillator therapy and mortality after implantable cardioverter-defibrillator generator replacement: results from a real-world nationwide cohort.

Ruwald MH, Ruwald AC, Johansen JB, Gislason G, Nielsen JC, Philbert B, Riahi S, Vinther M, Lindhardt TB.

Europace. 2019 Apr 27. pii: euz121. doi: 10.1093/europace/euz121. [Epub ahead of print]

PMID:
31329849
3.

Hidden burden of arrhythmias in patients with small atrial septal defects: a nationwide study.

Udholm S, Nyboe C, Redington A, Nielsen-Kudsk JE, Nielsen JC, Hjortdal VE.

Open Heart. 2019 Jun 29;6(1):e001056. doi: 10.1136/openhrt-2019-001056. eCollection 2019.

4.

The effect of implantable cardioverter-defibrillator in patients with diabetes and non-ischaemic systolic heart failure.

Rørth R, Thune JJ, Nielsen JC, Haarbo J, Videbæk L, Korup E, Signorovitch J, Bruun NE, Eiskjær H, Hassager C, Svendsen JH, Høfsten DE, Torp-Pedersen C, Pehrson S, Køber L, Kristensen SL.

Europace. 2019 Apr 28. pii: euz114. doi: 10.1093/europace/euz114. [Epub ahead of print]

PMID:
31323662
5.

Risk Models for Prediction of Implantable Cardioverter-Defibrillator Benefit: Insights From the DANISH Trial.

Kristensen SL, Levy WC, Shadman R, Nielsen JC, Haarbo J, Videbæk L, Bruun NE, Eiskjær H, Wiggers H, Brandes A, Thøgersen AM, Hassager C, Svendsen JH, Høfsten DE, Torp-Pedersen C, Pehrson S, Signorovitch J, Køber L, Thune JJ.

JACC Heart Fail. 2019 Aug;7(8):717-724. doi: 10.1016/j.jchf.2019.03.019. Epub 2019 Jul 10.

PMID:
31302052
6.

Association between Type D personality and outcomes in patients with non-ischemic heart failure.

Bundgaard JS, Østergaard L, Gislason G, Thune JJ, Nielsen JC, Haarbo J, Videbæk L, Olesen LL, Thøgersen AM, Torp-Pedersen C, Pedersen SS, Køber L, Mogensen UM.

Qual Life Res. 2019 Jul 10. doi: 10.1007/s11136-019-02241-6. [Epub ahead of print]

PMID:
31292822
7.

Electrically vs. imaging-guided left ventricular lead placement in cardiac resynchronization therapy: a randomized controlled trial.

Stephansen C, Sommer A, Kronborg MB, Jensen JM, Nørgaard BL, Gerdes C, Kristensen J, Jensen HK, Fyenbo DB, Bouchelouche K, Nielsen JC.

Europace. 2019 Jul 4. pii: euz184. doi: 10.1093/europace/euz184. [Epub ahead of print]

PMID:
31274152
8.

Combined obeticholic acid and elafibranor treatment promotes additive liver histological improvements in a diet-induced ob/ob mouse model of biopsy-confirmed NASH.

Roth JD, Veidal SS, Fensholdt LKD, Rigbolt KTG, Papazyan R, Nielsen JC, Feigh M, Vrang N, Young M, Jelsing J, Adorini L, Hansen HH.

Sci Rep. 2019 Jun 21;9(1):9046. doi: 10.1038/s41598-019-45178-z.

9.

Clinical practice and implementation of guidelines for the prevention, diagnosis and management of cardiac implantable electronic device infections: results of a worldwide survey under the auspices of the European Heart Rhythm Association.

Traykov V, Bongiorni MG, Boriani G, Burri H, Costa R, Dagres N, Deharo JC, Epstein LM, Erba PA, Snygg-Martin U, Nielsen JC, Poole JE, Saghy L, Starck C, Strathmore N, Blomström-Lundqvist C.

Europace. 2019 Jun 17. pii: euz137. doi: 10.1093/europace/euz137. [Epub ahead of print]

PMID:
31209483
10.

Incidence of device-related infection in 97 750 patients: clinical data from the complete Danish device-cohort (1982-2018).

Olsen T, Jørgensen OD, Nielsen JC, Thøgersen AM, Philbert BT, Johansen JB.

Eur Heart J. 2019 Jun 14;40(23):1862-1869. doi: 10.1093/eurheartj/ehz316.

11.

Outcome after catheter ablation for left atrial flutter.

Giehm-Reese M, Lukac P, Kristiansen SB, Jensen HK, Gerdes C, Kristensen J, Nielsen JM, Kronborg MB, Nielsen JC.

Scand Cardiovasc J. 2019 Jun;53(3):133-140. doi: 10.1080/14017431.2019.1612086. Epub 2019 May 12.

PMID:
31032647
12.

Comparative Transcriptome Analysis Shows Conserved Metabolic Regulation during Production of Secondary Metabolites in Filamentous Fungi.

Nielsen JC, Prigent S, Grijseels S, Workman M, Ji B, Nielsen J.

mSystems. 2019 Apr 16;4(2). pii: e00012-19. doi: 10.1128/mSystems.00012-19. eCollection 2019 Mar-Apr.

13.

An unusually late dislodged atrial lead catching externalized ICD-lead conductor. A rare cause of simultaneous atrial and ICD lead over-sensing.

Kristensen J, Kronborg MB, Lukac P, Nielsen JC.

J Arrhythm. 2019 Jan 24;35(2):307-310. doi: 10.1002/joa3.12155. eCollection 2019 Apr. No abstract available.

14.

GIGYF1/2-Driven Cooperation between ZNF598 and TTP in Posttranscriptional Regulation of Inflammatory Signaling.

Tollenaere MAX, Tiedje C, Rasmussen S, Nielsen JC, Vind AC, Blasius M, Batth TS, Mailand N, Olsen JV, Gaestel M, Bekker-Jensen S.

Cell Rep. 2019 Mar 26;26(13):3511-3521.e4. doi: 10.1016/j.celrep.2019.03.006.

15.

External continuous ECG versus loop recording for atrial fibrillation detection in patients who had a stroke.

Sejr MH, May O, Damgaard D, Sandal BF, Nielsen JC.

Heart. 2019 Jun;105(11):848-854. doi: 10.1136/heartjnl-2018-314186. Epub 2019 Mar 21.

PMID:
30898849
16.

Appropriate use of genetics in a young patient with atrioventricular block and family history of sudden cardiac death.

Rudbeck-Resdal J, Nielsen JC, Bundgaard H, Jensen HK.

HeartRhythm Case Rep. 2018 Dec 18;5(3):169-172. doi: 10.1016/j.hrcr.2018.12.004. eCollection 2019 Mar. No abstract available.

17.

Predicting stroke in patients without atrial fibrillation.

Steensig K, Olesen KKW, Thim T, Nielsen JC, Madsen M, Jensen SE, Jensen LO, Kristensen SD, Lip GYH, Maeng M.

Eur J Clin Invest. 2019 Mar 18:e13103. doi: 10.1111/eci.13103. [Epub ahead of print]

PMID:
30883728
18.

Implant-based multi-parameter telemonitoring of patients with heart failure and a defibrillator with vs. without cardiac resynchronization therapy option: a subanalysis of the IN-TIME trial.

Geller JC, Lewalter T, Bruun NE, Taborsky M, Bode F, Nielsen JC, Stellbrink C, Schön S, Mühling H, Oswald H, Reif S, Kääb S, Illes P, Proff J, Dagres N, Hindricks G; IN-TIME Study Group.

Clin Res Cardiol. 2019 Mar 14. doi: 10.1007/s00392-019-01447-5. [Epub ahead of print]

PMID:
30874886
19.

The impact of implantable cardioverter-defibrillator implantation on health-related quality of life in the DANISH trial.

Bundgaard JS, Thune JJ, Nielsen JC, Videbæk R, Haarbo J, Bruun NE, Videbæk L, Aagaard D, Korup E, Jensen G, Hildebrandt P, Steffensen FH, Eiskjær H, Brandes A, Thøgersen AM, Melchior TM, Pedersen OD, Gustafsson F, Egstrup K, Hassager C, Svendsen JH, Høfsten DE, Torp-Pedersen C, Pedersen SS, Pehrson S, Køber L, Mogensen UM.

Europace. 2019 Jun 1;21(6):900-908. doi: 10.1093/europace/euz018.

PMID:
30796456
20.

Significant regional variation in use of implantable cardioverter-defibrillators in Denmark.

Pedersen SB, Farkas DK, Hjortshøj SP, Bøtker HE, Johansen JB, Philbert BT, Haarbo J, Thomsen RW, Nielsen JC.

Eur Heart J Qual Care Clin Outcomes. 2019 Feb 20. pii: qcz008. doi: 10.1093/ehjqcco/qcz008. [Epub ahead of print]

PMID:
30785188
21.

Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.

Suppli MP, Rigbolt KTG, Veidal SS, Heebøll S, Eriksen PL, Demant M, Bagger JI, Nielsen JC, Oró D, Thrane SW, Lund A, Strandberg C, Kønig MJ, Vilsbøll T, Vrang N, Thomsen KL, Grønbæk H, Jelsing J, Hansen HH, Knop FK.

Am J Physiol Gastrointest Liver Physiol. 2019 Apr 1;316(4):G462-G472. doi: 10.1152/ajpgi.00358.2018. Epub 2019 Jan 17.

PMID:
30653341
22.

Identification of the decumbenone biosynthetic gene cluster in Penicillium decumbens and the importance for production of calbistrin.

Grijseels S, Pohl C, Nielsen JC, Wasil Z, Nygård Y, Nielsen J, Frisvad JC, Nielsen KF, Workman M, Larsen TO, Driessen AJM, Frandsen RJN.

Fungal Biol Biotechnol. 2018 Dec 19;5:18. doi: 10.1186/s40694-018-0063-4. eCollection 2018.

23.

Survey on the research activities within the EHRA Young EP community.

Vernooy K, Kutyifa V, Conte G, Bogdan S, Balsam P, Nielsen JC, Kosiuk J.

Europace. 2019 Apr 1;21(4):670-672. doi: 10.1093/europace/euy294. No abstract available.

PMID:
30535243
24.

Clinical outcome in patients with implantable cardioverter-defibrillator and cancer: a nationwide study.

Christensen AM, Bjerre J, Schou M, Jons C, Vinther M, Gislason GH, Johansen JB, Nielsen JC, Petersen HH, Riahi S, Ruwald AC.

Europace. 2019 Mar 1;21(3):465-474. doi: 10.1093/europace/euy268.

PMID:
30535192
25.

Reproducibility of measuring QRS duration and implications for optimization of interventricular pacing delay in cardiac resynchronization therapy.

Stephansen C, Kronborg MB, Witt CT, Kristensen J, Gerdes C, Sommer A, Jensen JM, Nielsen JC.

Ann Noninvasive Electrocardiol. 2019 May;24(3):e12621. doi: 10.1111/anec.12621. Epub 2018 Dec 6.

PMID:
30521128
26.

Current status of interventional cardiac electrophysiology training in ESC member countries: an EHRA Young EP Report.

Conte G, Kosiuk J, Bogdan S, Balsam P, Vernooy K, Nielsen JC, Kutyifa V.

Europace. 2019 Mar 1;21(3):522-524. doi: 10.1093/europace/euy277. No abstract available.

PMID:
30481298
27.

Should the Presence or Extent of Coronary Artery Disease be Quantified in the CHA2DS2-VASc Score in Atrial Fibrillation? A Report from the Western Denmark Heart Registry.

Steensig K, Olesen KKW, Thim T, Nielsen JC, Jensen SE, Jensen LO, Kristensen SD, Bøtker HE, Lip GYH, Maeng M.

Thromb Haemost. 2018 Dec;118(12):2162-2170. doi: 10.1055/s-0038-1675401. Epub 2018 Nov 12.

PMID:
30419601
28.

Transmural Myocardial Scar Assessed by Cardiac Computed Tomography: Predictor of Echocardiographic Versus Clinical Response to Cardiac Resynchronization Therapy?

Fyenbo DB, Sommer A, Kühl JT, Kofoed KF, Nørgaard BL, Kronborg MB, Bouchelouche K, Nielsen JC.

J Comput Assist Tomogr. 2019 Mar/Apr;43(2):312-316. doi: 10.1097/RCT.0000000000000824.

PMID:
30407247
29.
30.

Left Ventricular Mass Quantification by Two-Dimensional Echocardiography in a Pediatric Population: Correlation with Cardiac Magnetic Resonance Imaging.

Chu BJ, Lee T, Gilbreth JG, Nielsen JC, Ludomirsky A, Tretter JT, Bhatla P.

Pediatr Cardiol. 2019 Feb;40(2):412-420. doi: 10.1007/s00246-018-1991-8. Epub 2018 Oct 11.

PMID:
30310940
31.

CAD Is an Independent Risk Factor for Stroke Among Patients With Atrial Fibrillation.

Steensig K, Olesen KKW, Thim T, Nielsen JC, Jensen SE, Jensen LO, Kristensen SD, Bøtker HE, Lip GYH, Maeng M.

J Am Coll Cardiol. 2018 Nov 13;72(20):2540-2542. doi: 10.1016/j.jacc.2018.08.1046. Epub 2018 Aug 26. No abstract available.

PMID:
30157457
32.

Remote monitoring and clinical outcomes: details on information flow and workflow in the IN-TIME study.

Husser D, Christoph Geller J, Taborsky M, Schomburg R, Bode F, Nielsen JC, Stellbrink C, Meincke C, Hjortshøj SP, Schrader J, Lewalter T, Hindricks G.

Eur Heart J Qual Care Clin Outcomes. 2019 Apr 1;5(2):136-144. doi: 10.1093/ehjqcco/qcy031.

33.

Effectiveness of a comprehensive interactive eHealth intervention on patient-reported and clinical outcomes in patients with an implantable cardioverter defibrillator [ACQUIRE-ICD trial]: study protocol of a national Danish randomised controlled trial.

Pedersen SS, Skovbakke SJ, Wiil UK, Schmidt T, dePont Christensen R, Brandt CJ, Sørensen J, Vinther M, Larroudé CE, Melchior TM, Riahi S, Smolderen KGE, Spertus JA, Johansen JB, Nielsen JC.

BMC Cardiovasc Disord. 2018 Jul 3;18(1):136. doi: 10.1186/s12872-018-0872-7.

34.

Osmotic Stress Blocks Mobility and Dynamic Regulation of Centriolar Satellites.

Nielsen JC, Nordgaard C, Tollenaere MAX, Bekker-Jensen S.

Cells. 2018 Jun 22;7(7). pii: E65. doi: 10.3390/cells7070065.

35.

The time is not ripe for the wearable cardioverter-defibrillator.

Nielsen JC, Johansen JB.

Europace. 2018 Sep 1;20(FI2):f146-f147. doi: 10.1093/europace/euy135. No abstract available.

PMID:
29905810
36.

Reconstruction of 24 Penicillium genome-scale metabolic models shows diversity based on their secondary metabolism.

Prigent S, Nielsen JC, Frisvad JC, Nielsen J.

Biotechnol Bioeng. 2018 Oct;115(10):2604-2612. doi: 10.1002/bit.26739. Epub 2018 Jul 25.

PMID:
29873086
37.

Time until diagnosis of clinical events with different remote monitoring systems in implantable cardioverter-defibrillator patients.

Söth-Hansen M, Witt CT, Rasmussen M, Kristensen J, Gerdes C, Nielsen JC.

Heart Rhythm. 2018 Nov;15(11):1648-1654. doi: 10.1016/j.hrthm.2018.05.025. Epub 2018 May 24.

PMID:
29803850
38.

Implantable cardioverter-defibrillator therapy and device-related complications in young patients with inherited cardiomyopathies or channelopathies: a 17-year cohort study.

Petersen LDD, Christiansen MK, Pedersen LN, Nielsen JC, Broendberg AK, Jensen HK.

Europace. 2018 Nov 1;20(11):1849-1855. doi: 10.1093/europace/euy081.

PMID:
29697814
39.

Importance of beta-blocker dose in prevention of ventricular tachyarrhythmias, heart failure hospitalizations, and death in primary prevention implantable cardioverter-defibrillator recipients: a Danish nationwide cohort study.

Ruwald AC, Gislason GH, Vinther M, Johansen JB, Nielsen JC, Philbert BT, Torp-Pedersen C, Riahi S, Jøns C.

Europace. 2018 Sep 1;20(FI2):f217-f224. doi: 10.1093/europace/euy077.

PMID:
29684191
40.

Left ventricular regional remodeling and lead position during cardiac resynchronization therapy.

Kronborg MB, Sommer A, Fyenbo DB, Norgaard BL, Gerdes C, Jensen JM, Jensen HK, Kristensen J, Nielsen JC.

Heart Rhythm. 2018 Oct;15(10):1542-1549. doi: 10.1016/j.hrthm.2018.04.012. Epub 2018 Apr 18.

PMID:
29678780
41.

Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation.

Kirchhof P, Haeusler KG, Blank B, De Bono J, Callans D, Elvan A, Fetsch T, Van Gelder IC, Gentlesk P, Grimaldi M, Hansen J, Hindricks G, Al-Khalidi HR, Massaro T, Mont L, Nielsen JC, Nölker G, Piccini JP, De Potter T, Scherr D, Schotten U, Themistoclakis S, Todd D, Vijgen J, Di Biase L.

Eur Heart J. 2018 Aug 21;39(32):2942-2955. doi: 10.1093/eurheartj/ehy176.

42.

Longer inter-lead electrical delay is associated with response to cardiac resynchronization therapy in patients with presumed optimal left ventricular lead position.

Sommer A, Kronborg MB, Nørgaard BL, Stephansen C, Poulsen SH, Kristensen J, Gerdes C, Nielsen JC.

Europace. 2018 Oct 1;20(10):1630-1637. doi: 10.1093/europace/eux384.

PMID:
29377984
43.

Targeted next generation sequencing in a young population with suspected inherited malignant cardiac arrhythmias.

Broendberg AK, Christiansen MK, Nielsen JC, Pedersen LN, Jensen HK.

Eur J Hum Genet. 2018 Mar;26(3):303-313. doi: 10.1038/s41431-017-0060-8. Epub 2018 Jan 17.

44.

Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference.

Kotecha D, Breithardt G, Camm AJ, Lip GYH, Schotten U, Ahlsson A, Arnar D, Atar D, Auricchio A, Bax J, Benussi S, Blomstrom-Lundqvist C, Borggrefe M, Boriani G, Brandes A, Calkins H, Casadei B, Castellá M, Chua W, Crijns H, Dobrev D, Fabritz L, Feuring M, Freedman B, Gerth A, Goette A, Guasch E, Haase D, Hatem S, Haeusler KG, Heidbuchel H, Hendriks J, Hunter C, Kääb S, Kespohl S, Landmesser U, Lane DA, Lewalter T, Mont L, Nabauer M, Nielsen JC, Oeff M, Oldgren J, Oto A, Pison L, Potpara T, Ravens U, Richard-Lordereau I, Rienstra M, Savelieva I, Schnabel R, Sinner MF, Sommer P, Themistoclakis S, Van Gelder IC, Vardas PE, Verma A, Wakili R, Weber E, Werring D, Willems S, Ziegler A, Hindricks G, Kirchhof P.

Europace. 2018 Mar 1;20(3):395-407. doi: 10.1093/europace/eux318.

45.

Recurrence after pulmonary vein isolation is associated with low contact force.

Tofig BJ, Lukac P, Borregaard R, Nielsen JM, Jensen HK, Gerdes C, Kristensen J, Nielsen JC, Kristiansen SB.

Scand Cardiovasc J. 2018 Feb;52(1):28-33. doi: 10.1080/14017431.2017.1405067. Epub 2017 Nov 30.

PMID:
29191055
46.

Correction to: Industrial antifoam agents impair ethanol fermentation and induce stress responses in yeast cells.

Nielsen JC, Lino FSO, Rasmussen TG, Thykær J, Workman CT, Basso TO.

Appl Microbiol Biotechnol. 2018 Jan;102(1):513. doi: 10.1007/s00253-017-8643-4.

47.

Physiological characterization of secondary metabolite producing Penicillium cell factories.

Grijseels S, Nielsen JC, Nielsen J, Larsen TO, Frisvad JC, Nielsen KF, Frandsen RJN, Workman M.

Fungal Biol Biotechnol. 2017 Oct 17;4:8. doi: 10.1186/s40694-017-0036-z. eCollection 2017.

48.

Development of fungal cell factories for the production of secondary metabolites: Linking genomics and metabolism.

Nielsen JC, Nielsen J.

Synth Syst Biotechnol. 2017 Feb 28;2(1):5-12. doi: 10.1016/j.synbio.2017.02.002. eCollection 2017 Mar. Review.

49.

The impact of supraventricular ectopic complexes in different age groups and risk of recurrent atrial fibrillation after antiarrhythmic medication or catheter ablation.

Alhede C, Lauridsen TK, Johannessen A, Dixen U, Jensen JS, Raatikainen P, Hindricks G, Walfridsson H, Kongstad O, Pehrson S, Englund A, Hartikainen J, Hansen PS, Nielsen JC, Jons C.

Int J Cardiol. 2018 Jan 1;250:122-127. doi: 10.1016/j.ijcard.2017.09.208. Epub 2017 Oct 9.

PMID:
29050922
50.

Association between implantable cardioverter-defibrillator therapy and different lead positions in patients with cardiac resynchronization therapy.

Kronborg MB, Johansen JB, Haarbo J, Riahi S, Philbert BT, Jørgensen OD, Nielsen JC.

Europace. 2018 Sep 1;20(9):e133-e139. doi: 10.1093/europace/eux296.

PMID:
29036292

Supplemental Content

Loading ...
Support Center